对话分析
宏观分析
个别股票
Alpha 实验室
实用工具
Menu
我的活动
ZH
登录
ZH
暴跌分析
/
Endra Life Sciences Inc.
/
2026-06-25
▼ PLUNGE
Endra Life Sciences Inc.
-31.4%
NDRA
NASDAQ
Healthcare
2026-06-25
4.3
收盘价
6.27
前收盘价
-31.42%
涨幅
8.3x
量比
暴跌原因
2026년 6월 1일, Ascendiant Capital은 ENDRA Life Sciences에 대해 '매수(Buy)' 의견을 유지했으나 목표 주가를 25달러로 하향 조정했다.
·
2026년 6월 1일, Ascendiant Capital은 ENDRA Life Sciences에 대해 '매수(Buy)' 의견을 유지했으나 목표 주가를 25달러로 하향 조정했다.
相关新闻
Ascendiant Capital Maintains Buy on ENDRA Life Sciences, Lowers Price Target to $25 - ENDRA Life Sciences
Benzinga
2026-06-01
Neumora Therapeutics to Participate in 25th Annual Needham Virtu
Gurufocus
2026-04-06
Neumora lines up April 13 Needham healthcare conference webcast
Stocktitan
2026-04-06
Deal Dispatch: Estée Lauder Considers Merger, KKR Buys Nothing Bundt Cakes, Amazon Acquires Fauna Robotics - Abbott Laboratories (NYSE:ABT), Amazon (NASDAQ:AMZN)
Benzinga
2026-03-27
Enveric Biosciences shares are trading higher after the FDA announced accelerated efforts to advance trea
Benzinga
2026-04-24
技术分析
信号
MACD看涨
跌破SMA20
关键指标
43.66
RSI (14)
4.88
SMA 20
3.78
Bollinger Lower
5.98
Bollinger Upper
4.88
Bollinger Mid
0.00
MACD
-0.06
MACD Signal
0.07
MACD Hist
查看股票详情
返回暴涨股列表
首页
聊天
组合
活动
菜单
Endra Life Sciences Inc. +-31.4% 暴涨分析 (2026-06-25) | Alpha Lenz